A matr3-tfe3 fusion gene and detection primer and application thereof
A MATR3-TFE3, fusion gene technology, applied in the field of medical testing, can solve the problems of long testing period, scarce testing platform, and high sample quality requirements, achieve reliable detection rate, improve detection rate and accuracy, and expand detection range. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] Embodiment 1 is verified for the case of definite diagnosis:
[0027] For cases in which new fusion sites of MATR3 exon15-TFE3 exon4 were detected by high-throughput sequencing RNA-seq, the primers we designed were used for verification.
[0028] 1. Extraction of RNA:
[0029] Strictly follow the RNeasy FFPE Kit operating instructions for extraction. ① Dewaxing: dewax the collected slides with xylene, rinse with absolute ethanol, air-dry and scrape off with a scalpel blade and put them into a 1.5ml EP tube; Proteinase K, mix well, enzymatically digest at 56°C for 15min, then at 80°C for 15min, cool on ice; ③add 16μl DNase buffer, then add 10μl DNase I, mix well, let stand at room temperature for 15min, centrifuge at 12000rpm for 15min, and take the supernatant;④ Add 320μl of binding solution and 720μl of absolute ethanol, mix well, transfer to the adsorption column twice, centrifuge at 8000rpm for 1min, discard the waste liquid; ⑤Wash: add 500μl of washing solution, c...
Embodiment 2
[0033] Example 2 Detection of Xp11.2 tumors with unknown translocation partners
[0034] We used the primer combination of the present invention to detect 35 Xp11.2 tumors with unknown translocation partners, and the RNA extraction, reverse transcription PCR and sequencing methods were the same as above.
[0035] Result: using the primer combination detection designed by the present invention, a total of 1 case detected the MATR3-TFE3 fusion gene ( image 3 , Figure 4 ), verified by immunohistochemistry, fluorescence in situ hybridization and other methods, the results are true and reliable.
[0036] Evaluation: The primer combination of the present invention is a supplement to the original Xp11.2 fusion gene primers, covers the unreported sites of the TFF3 fusion gene, and increases the detection rate of the RT-PCR method for diagnosing the tumor.
[0037] Nanjing General Hospital of Nanjing Military Region of the Chinese People's Liberation Army
[0038] A MATR3-TFE3 f...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


